市場調查報告書
商品編碼
1423564
2030 年醫用 X 光市場預測:按類型、攜帶性、技術、應用、最終用戶和地區進行的全球分析Medical X-Ray Market Forecasts to 2030 - Global Analysis By Type, Portability, Technology, Application, End User and By Geography |
根據Stratistics MRC預測,2023年全球醫用X光市場規模將達145億美元,預計2030年將達到246億美元,預測期內複合年成長率為7.8%。
醫用 X 光是電磁輻射的一種型態,用於診斷成像,以創建體內的詳細影像。 X光是透過將受控量的輻射穿過身體並照射到專用檢測器上而產生的。骨骼等緻密組織吸收大量輻射,因此在 X 光影像中呈現白色,但軟組織傳輸大量輻射,因此呈現各種灰色陰影。 X 光通常用於透過提供骨骼、器官和組織等內部結構的詳細影像來診斷骨折、感染疾病、腫瘤和其他疾病。 X 光是醫療保健專業人員診斷和治療各種疾病的寶貴工具。
根據 Bioinformatics Inc. 發表的一項研究報告,IMV 2021 年的調查發現,美國醫院放射科安裝的移動X光設備中約有88.0% 使用數位技術,12.0% 使用CR 暗盒/我們得出結論,它使用模擬技術。
醫療保健支出不斷成長
隨著許多地區醫療保健支出持續成長,對先進醫療設備(包括X光設備和影像處理技術)的投資也同步增加。醫療保健支出的增加使得電腦斷層掃描 (CT) 和磁振造影(MRI) 等先進影像技術的引入成為可能,這些技術可提供詳細的解剖資訊。最終,這些進步有助於建立更有效率、更有效的醫療保健系統。
高輻射風險增加
考慮到 X光損傷身體細胞的風險,患者對 X 光的偏好下降可能會限制產業進步。 X光的能量比光波高,產生高能量輻射,增加癌症負擔。因此,X光檢查次數的增加可能會阻礙市場佔有率。 X光也會產生電離輻射,導致產前和產後接觸輻射,對兒童健康產生負面影響。
重視早期診斷
資金籌措的增加使得開發和引進具有更高影像品質和更低輻射劑量的先進 X 光技術成為可能,例如數位 X 光成像和透視。這些進步有助於早期發現疾病和病理,從而實現快速干預並改善患者的治療結果。疾病的早期發現和診斷已成為醫療保健的優先事項。 X 光在早期發現和治療各種醫療狀況方面發揮著重要作用,有助於市場成長。
缺乏即時影像
傳統的X光影像產生靜態影像,無法即時捕捉身體內部運動和動態過程。此限制使其不適合評估某些需要即時監測的情況,例如血流或關節活動度。然而,X 光可能無法提供足夠的資訊來診斷某些疾病,例如早期癌症或輕微骨折。這些都是阻礙市場成長的因素。
這次疫情導致胸部 X 光檢查的需求增加,因為它們通常用於評估 COVID-19 患者的肺部病變。醫院和醫療機構對疑似病例和確診病例進行 X 光檢查的工作量正在增加。這場大流行促使研究和開發改進與 COVID-19 診斷和監測相關的 X光技術和技術。人們正在探索攜帶式X光設備和基於人工智慧的影像分析等創新,以提高效率和準確性。
胸部 X 光檢查預計將是預測期內最大的部分
胸部 X 光檢查預計將是預測期內最大的部分。胸部 X 光檢查是一種現成的診斷工具,因為其執行速度相對較快且是非侵入性的。此測試通常患者耐受性良好,且不需要注射或顯影劑。與電腦斷層掃描和磁振造影等其他影像方式相比,X 光檢查具有成本效益。
預計固定可攜式部分在預測期內將呈現最高的複合年成長率
預計固定攜帶細分市場在預測期間內將出現最高的複合年成長率。政府對安裝現代診斷設備的投資不斷增加,刺激了固定 X 光系統的採用。乳房X光檢查和牙科X光檢查的日益普及,有助於對頭骨、胸部、四肢、脊椎和腹部進行成像,也推動了市場前景。
由於美國醫療中心需要診斷 X 光的急診患者數量不斷增加,以及美國政府醫療計畫對數位 X 光系統有利的報銷環境,北美將在預測期內佔據最大的市場佔有率。私人和公共投資的增加提高了人們對早期診斷益處的認知。該地區有利的人口趨勢也支持了行業形勢。
由於癌症和心血管疾病等慢性病盛行率不斷上升,預計亞太地區在預測期內將維持最高的複合年成長率。與傳統系統相比,醫院和私人診所擴大採用數位 X 光系統,預計這將推動市場成長。因此,X光的採用有利於此類疾病的準確診斷和治療。預計這將推動該地區的市場成長。
According to Stratistics MRC, the Global Medical X-Ray Market is accounted for $14.5 billion in 2023 and is expected to reach $24.6 billion by 2030 growing at a CAGR of 7.8% during the forecast period. Medical X-ray refers to a form of electromagnetic radiation used in diagnostic imaging to create detailed images of the inside of the body. X-rays are produced by directing a controlled amount of radiation through the body onto a specialized detector. Dense tissues, such as bones, absorb more radiation and appear white on the resulting X-ray images, while softer tissues allow more radiation to pass through, appearing as varying shades of gray. X-rays are commonly used to diagnose fractures, infections, tumors, and other conditions by providing detailed images of internal structures like bones, organs, and tissues. They are valuable tools for healthcare professionals in determining and treating various medical conditions.
According to research study published by Bioinformatics Inc., in 2021, the IMV's 2021 survey concluded that about 88.0% of mobile X-ray units installed in the U.S. hospital radiology departments use digital technology and 12.0% use CR cassettes/analog technology.
Growing healthcare expenditure
As healthcare spending continues to rise in many regions, there's a parallel increase in investments in advanced medical equipment, including X-ray machines and imaging technologies. Higher healthcare spending enables the implementation of advanced imaging techniques, such as computed tomography (CT) and magnetic resonance imaging (MRI), which provide detailed anatomical information. Ultimately, these advancements contribute to a more efficient and effective healthcare system.
Increasing risks of high radiation
The declining patient preference for X-rays considering their risks of harming the body cells may pose as a constraint for the industry progress. X-rays have high energy as compared to light waves, and thus offer high-energy radiation, subsequently increasing the burden of cancer. Hence the rising number of performed x-ray tests may hinder the market share. X-rays also lead to ionizing radiations resulting in pre-and postnatal irradiation, bringing adverse health impacts for children.
Focus on early diagnosis
Increased funding allows for the development and deployment of advanced X-ray technologies, such as digital radiography and fluoroscopy, which offer higher image quality and lower radiation doses. These advancements facilitate the early detection of diseases and conditions, enabling prompt intervention and improved patient outcomes. Early detection and diagnosis of diseases are becoming a healthcare priority. X-rays play a crucial role in enabling early identification and treatment of various medical conditions, contributing to market growth.
Lack of real-time imaging
Traditional X-ray imaging produces static images, which means it cannot capture real-time movements or dynamic processes within the body. This limitation makes it less suitable for assessing certain conditions that require real-time monitoring, such as blood flow or joint mobility. However, X-rays may not provide sufficient information for diagnosing certain conditions, such as early-stage cancers or subtle fractures. These are the factors hampering the growth of the market.
The pandemic has led to a higher demand for chest X-rays as they are commonly used to assess lung involvement in COVID-19 patients. Hospitals and healthcare facilities have experienced an increased workload in conducting X-rays for suspected or confirmed cases. The pandemic has prompted research and development efforts to improve X-ray technology and techniques related to COVID-19 diagnosis and monitoring. Innovations such as portable X-ray devices and AI-based image analysis have been explored to enhance efficiency and accuracy.
The chest x-rays segment is expected to be the largest during the forecast period
The chest x-rays segment is expected to be the largest during the forecast period. Chest X-rays are relatively quick to perform and non-invasive, making them a readily available diagnostic tool. The procedure is generally well-tolerated by patients and does not require any injections or contrast agents. X-rays are more cost-effective compared to other imaging modalities such as computed tomography scans or magnetic resonance imaging.
The fixed portability segment is expected to have the highest CAGR during the forecast period
The fixed portability segment is expected to have the highest CAGR during the forecast period. The rising number of government investments for installing modern diagnostic equipment has spurred the adoption of fixed x-ray systems as they can be accessed in a wide variety of sizes and types in several high-end scientific applications. The rising popularity of mammograms and dental x-rays for facilitating the imaging of skull, chest, extremities, spine, and abdomen will also add to the market outlook.
North America is projected to hold the largest market share during the forecast period due to rising emergency patient visits across U.S. healthcare centers requiring diagnostic x-rays and favorable reimbursement environment by government healthcare programs in the U.S. for digital x-ray systems. The growing number of private and public investments has propelled the rising awareness regarding the advantages of early diagnosis. The presence of favorable demographic trends in the region will also compliment the industry landscape.
Asia Pacific is projected to hold the highest CAGR over the forecast period due to the rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and others. The increase in adoption of digital X-ray system over traditional systems by hospitals and private clinics is expected to boost the growth of the market. Therefore, the adoption of x-rays is beneficial for the accurate diagnosis and treatment of such disorders. This is anticipated to drive the market growth in the region.
Key players in the market
Some of the key players in Medical X-Ray market include Hitachi, Ltd., Hologic, Inc., Allengers Medical Systems Limited, Eurocolumbus s.r.l., Varian Medical Systems, Inc., Vieworks Co., Ltd., Koninklijke Philips N.V., Canon Medical Systems Corporation, Carestream Health, Inc., Shimadzu Corporation, Fujifilm Holdings Corporation, Ziehm Imaging GmbH, Analogic Corporation, Samsung Medison Co., Ltd., Agfa-Gevaert N.V., BMI Biomedical International s.r.l., Control-X Medical GmbH, Siemens Healthcare Private Limited and Poskom Co., Ltd.
In April 2023, Shimadzu Corporation, a biotechnology research company, released the EZy-Rad Pro radiography system for clinics. It improved to ensure the system can be easily operated by healthcare personnel. In addition, Shimadzu will also help reduce the burden on patients by shortening examination times.
In July 2022, Siemens Healthcare GmbH launched its Multix Impact E X-ray system at European Congress of Radiology (ECR) in Vienna. The launch of the system broadened access to healthcare care at an affordable cost.
In March 2022, NeuroLogica Corp., the U.S. subsidiary of SAMSUNG ELECTRONICS CO., LTD., announced that the company's digital radiography and ultrasound business would operate under a new brand called Boston Imaging to provide innovative medical devices to the market.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.